Yucel Idris, Guzin Gonullu
Department of Medical Oncology, Ondokuz Mayis University Medical School, Samsun 55139, Turkey.
Invest New Drugs. 2008 Apr;26(2):189-92. doi: 10.1007/s10637-007-9082-3. Epub 2007 Sep 21.
Capecitabine is a chemotherapeutic drug for use in cancers. Hand-foot syndrome (HFS) is side effect of capecitabine which can lead the cessation of the therapy or dose reduction. Henna (Lawsonia inermis) is a traditionally used plant of Middle-East that is applied on hands and feet. Some of cancer patients in capecitabine treatment who developed HFS, we recommended to apply henna. In these patients, six patients were grade 3 HFS and four were grade 2 HFS. Complete response (CR) were seen in four of grade 3 HFS and all of grade 2; two grade 3 HFS improved to grade 1. So far, in the chemotherapy, there was no need of dose reduction and also no side effect of henna seen. Clinical improvement in these patients may relate to anti-inflammatory, antipyretic and analgesic effects of henna. Prospective studies are needed to show this therapeutic effect of henna.
卡培他滨是一种用于癌症治疗的化疗药物。手足综合征(HFS)是卡培他滨的副作用,可导致治疗中断或剂量减少。指甲花(散沫花)是中东地区传统使用的一种植物,用于手足部位。对于一些接受卡培他滨治疗且出现HFS的癌症患者,我们建议使用指甲花。在这些患者中,6例为3级HFS,4例为2级HFS。4例3级HFS患者和所有2级HFS患者均出现完全缓解(CR);2例3级HFS患者改善为1级。到目前为止,在化疗过程中,无需减少剂量,也未观察到指甲花的副作用。这些患者的临床改善可能与指甲花的抗炎、解热和镇痛作用有关。需要进行前瞻性研究来证实指甲花的这种治疗效果。